Ginkgo Bioworks (DNA) Expected to Announce Earnings on Thursday

Ginkgo Bioworks (NYSE:DNA) will likely be issuing its quarterly earnings data after the market closes on Thursday, March 6th. Analysts expect the company to announce earnings of ($1.45) per share and revenue of $44.43 million for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

Ginkgo Bioworks Price Performance

NYSE DNA opened at $8.13 on Wednesday. The business’s fifty day moving average price is $11.46 and its 200-day moving average price is $9.43. The stock has a market capitalization of $467.02 million, a price-to-earnings ratio of -0.62 and a beta of 1.16. Ginkgo Bioworks has a 1-year low of $5.26 and a 1-year high of $51.20.

About Ginkgo Bioworks

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.